Skip to main content
Premium Trial:

Request an Annual Quote

Claritas Wins NY State Approval for Three Dx Tests

NEW YORK (GenomeWeb) – Claritas Genomics announced today that it has received New York State (NYS) Department of Health approval for its bone marrow failure, hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), and nephrotic syndrome region of interest tests, as well as a mitochondrial DNA assay.

HLH is a rare disorder characterized by severe inflammation due to the proliferation of lymphocytes and macrophages, and includes some forms of MAS. Claritas' test evaluates 20 genes associated with the conditions. The nephrotic syndrome test focuses on 42 genes linked to the kidney disorder, while the bone marrow failure assay covers 87 genes.

According to the company — which was created by Boston Children's Hospital and Cincinnati Children's Hospital in partnership with Cerner, Wuxi NextCode Genomics, and Thermo Fisher Scientific — it now offers six tests with NYS approval, following clearance of its clinical exome and pediatric neurology region of interest tests in January.

All of Claritas' test are based on its dual-capture, dual-sequencing platform method. 

"New York State approval for our entire menu is a key component of our quality and regulatory strategy," Claritas Executive Chairman David Margulies said in a statement. "Claritas' combination of NYS, ISO 15189, and CLIA certification demonstrates our commitment to total quality management practice to ensure the best possible results for patients and families."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.